Environmental Health and Toxicology10.5620/eht.e20180022017331e2018002Use of adverse outcome pathways in chemical toxicity testing: potential advantages and limitationsJaeseong Jeong, Jinhee Choi,,
Journal of Dentistry10.1016/0300-5712(94)90032-9199422S6-S11Use of cell cultures for toxicity testing of dental materials—advantages and limitationsG. Schmalz,
Archives of Toxicology10.1007/s00204-012-0974-4201287113-14Stress response pathways, toxicity pathways and adverse outcome pathwaysPaul Jennings,,
In Silico Methods for Predicting Drug Toxicity10.1007/978-1-0716-1960-5_202022521-535Adverse Outcome Pathways as Versatile Tools in Liver Toxicity TestingEmma Arnesdotter, Eva Gijbels, Bruna dos Santos Rodrigues, Vânia Vilas-Boas, Mathieu Vinken
Toxicology Letters10.1016/s0378-4274(21)00412-42021350S70Adverse outcome pathways for uranium induced kidney toxicityY. Guéguen,
A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment10.1007/978-3-319-66084-4_102018199-218Use of Genetic Manipulation for Evaluating and Understanding Adverse Outcome PathwaysChristopher Warner, Natàlia Garcia-Reyero, Edward Perkins
A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment10.1007/978-3-319-66084-4_172018349-378Use of Adverse Outcome Pathways in Human Risk Assessment and ToxicologyCatherine Willett, Suzanne Fitzpatrick, Bette Meek, Carl Westmoreland
Reproductive Toxicology10.1016/j.reprotox.2014.07.01220144816Introduction: Adverse Outcome Pathways – Future for DART testingManon Beekhuijzen,
Alternatives to Animal Testing10.1007/978-981-13-2447-5_11201883-90The Use of Adverse Outcome Pathways (AOPs) to Support Chemical Safety Decisions Within the Context of Integrated Approaches to Testing and Assessment (IATA)Catherine Willett
In Silico Methods for Predicting Drug Toxicity10.1007/978-1-4939-3609-0_142016325-337Adverse Outcome Pathways as Tools to Assess Drug-Induced ToxicityMathieu Vinken